Skip to main content
Premium Trial:

Request an Annual Quote

Eureka to Provide Bioo Scientific with Next-Generation Sequencing Services


This story was originally published on August 18.

Bioo Scientific said last week that it has tapped Eureka Genomics as its next-generation sequencing service provider.

Bioo, a reagent and test-kit provider, is developing kits for next-generation sequencing sample preparation, among other applications. In May, it launched the AIR Small RNA-sequencing kit, a library prep kit for small RNA sequencing on the Illumina platform. The company also offers several products under its AIR line for Illumina small RNA sequencing, including barcoded adapters, adenylated linkers, ligase, and sequencing-grade adapters.

A Bioo spokesperson told In Sequence that the company is using Eureka's sequencing services for testing and verification of its next-gen sequencing products.

Bioo said in a statement that it evaluated "multiple service providers," and chose Eureka "based on their extensive sequencing experience, quick turnaround times and strong bioinformatics support."

Eureka began offering sequencing services based on the Illumina platform last year (IS 4/28/2009).

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.